NZ243310A - Pyrrolo[1,2-a]pyrazine or benzo[g]pyrazino[1,2-a]indole derivatives, pharmaceutical compositions thereof and intermediates therefor - Google Patents

Pyrrolo[1,2-a]pyrazine or benzo[g]pyrazino[1,2-a]indole derivatives, pharmaceutical compositions thereof and intermediates therefor

Info

Publication number
NZ243310A
NZ243310A NZ243310A NZ24331092A NZ243310A NZ 243310 A NZ243310 A NZ 243310A NZ 243310 A NZ243310 A NZ 243310A NZ 24331092 A NZ24331092 A NZ 24331092A NZ 243310 A NZ243310 A NZ 243310A
Authority
NZ
New Zealand
Prior art keywords
formula
solution
compound
substituted
methylene chloride
Prior art date
Application number
NZ243310A
Other languages
English (en)
Inventor
Stephan Rover
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NZ243310A publication Critical patent/NZ243310A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333—Radicals substituted by oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ243310A 1991-07-02 1992-06-25 Pyrrolo[1,2-a]pyrazine or benzo[g]pyrazino[1,2-a]indole derivatives, pharmaceutical compositions thereof and intermediates therefor NZ243310A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH195091 1991-07-02
CH166792 1992-05-22

Publications (1)

Publication Number Publication Date
NZ243310A true NZ243310A (en) 1994-11-25

Family

ID=25688329

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ243310A NZ243310A (en) 1991-07-02 1992-06-25 Pyrrolo[1,2-a]pyrazine or benzo[g]pyrazino[1,2-a]indole derivatives, pharmaceutical compositions thereof and intermediates therefor

Country Status (14)

Country Link
US (1) US5292732A (OSRAM)
EP (1) EP0521368A1 (OSRAM)
JP (1) JPH0774217B2 (OSRAM)
CN (1) CN1030986C (OSRAM)
AU (1) AU654362B2 (OSRAM)
CA (1) CA2072836A1 (OSRAM)
CS (1) CS202292A3 (OSRAM)
FI (1) FI100242B (OSRAM)
HU (1) HUT70163A (OSRAM)
IE (1) IE922152A1 (OSRAM)
IL (1) IL102337A (OSRAM)
NO (1) NO922604L (OSRAM)
NZ (1) NZ243310A (OSRAM)
TW (1) TW224974B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0572863A1 (de) * 1992-06-05 1993-12-08 F. Hoffmann-La Roche Ag ZNS Pyrazinoindole
US5378846A (en) * 1993-06-11 1995-01-03 Russian-American Institute For New Drug Development 1,2,3,4-tetrahydropyrrolo-[1,2-a]-pyrazine derivatives
US5352096A (en) * 1993-09-27 1994-10-04 Chi Wen Chen Air compressor for automobiles
TW334423B (en) * 1993-10-22 1998-06-21 Hoffmann La Roche Tricyclic 1-aminoethylpyrrole-derivatives
UA66370C2 (en) 1997-12-16 2004-05-17 Lilly Co Eli Arylpiperazines having activity to setotonin 1 receptors
HUP0201472A3 (en) 1998-12-25 2006-03-28 Shionogi & Co Aromatic heterocycle compounds having hiv integrase inhibiting activities
WO2004112699A2 (en) * 2003-06-12 2004-12-29 Merck & Co., Inc. Mitotic kinesin inhibitors
EP1741709A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
DE102006049452A1 (de) 2006-10-17 2008-05-08 Grünenthal GmbH Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln
SG185651A1 (en) 2010-06-09 2012-12-28 Janssen Pharmaceutica Nv 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
WO2012085038A1 (en) 2010-12-22 2012-06-28 Janssen Pharmaceutica Nv 5,6-DIHYDRO-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE)
WO2012117027A1 (en) 2011-03-01 2012-09-07 Janssen Pharmaceutica Nv 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace)
US9845326B2 (en) 2011-03-09 2017-12-19 Janssen Pharmaceutica Nv Substituted 3,4-dihydropyrrolo[1,2-A]pyrazines as beta-secretase (BACE) inhibitors
WO2014097147A1 (en) * 2012-12-19 2014-06-26 Novartis Ag Tricyclic compounds as cftr inhibitors
CN105452251B (zh) 2013-06-12 2017-12-26 詹森药业有限公司 作为β‑分泌酶(BACE)抑制剂的4‑氨基‑6‑苯基‑5,6‑二氢咪唑并[1,5‑A]吡嗪‑3(2H)‑酮衍生物
CN105324383B (zh) 2013-06-12 2017-10-31 詹森药业有限公司 作为β‑分泌酶(BACE)抑制剂的4‑氨基‑6‑苯基‑6,7‑二氢[1,2,3]三唑并[1,5‑A]吡嗪衍生物
WO2014198853A1 (en) 2013-06-12 2014-12-18 Janssen Pharmaceutica Nv 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (bace)
MX2017008083A (es) 2014-12-18 2017-10-31 Janssen Pharmaceutica Nv Compuestos 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2h-pirrol-5-amina inhibidores de beta-secretasa.
EP3609897A1 (en) * 2017-04-12 2020-02-19 H. Hoffnabb-La Roche Ag A method for labeling of aldehyde containing target molecules

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1185080A (en) * 1967-12-07 1970-03-18 Beecham Group Ltd Pyrrolidines
US3906010A (en) * 1974-06-17 1975-09-16 Morton Norwich Products Inc Series of 5-aryl-2-furamidines
US3931247A (en) * 1974-12-11 1976-01-06 Morton-Norwich Products, Inc. 5-(Substituted)phenylfurfuryl alcohols
JPS5811878B2 (ja) * 1974-12-19 1983-03-04 大正製薬株式会社 フロ （ ３ ２−ｂ ） インド−ルルイノ セイホウ
US4188389A (en) * 1978-11-03 1980-02-12 Ayerst Mckenna & Harrison, Inc. 1,2,3,4-Tetrahydropyrrolo(1,2-A)pyrazines
JPS5852995B2 (ja) * 1981-09-28 1983-11-26 武田薬品工業株式会社 フルフラ−ル誘導体の製造法
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents

Also Published As

Publication number Publication date
JPH06239865A (ja) 1994-08-30
IL102337A0 (en) 1993-01-14
NO922604L (no) 1993-01-04
US5292732A (en) 1994-03-08
IE922152A1 (en) 1993-01-13
IL102337A (en) 1996-01-31
NO922604D0 (no) 1992-07-01
FI923073A7 (fi) 1993-01-03
HUT70163A (en) 1995-09-28
CN1030986C (zh) 1996-02-14
CA2072836A1 (en) 1993-01-03
HU9202139D0 (en) 1992-10-28
JPH0774217B2 (ja) 1995-08-09
AU654362B2 (en) 1994-11-03
FI100242B (fi) 1997-10-31
FI923073A0 (fi) 1992-07-02
TW224974B (OSRAM) 1994-06-11
AU1930992A (en) 1993-01-07
CS202292A3 (en) 1993-01-13
EP0521368A1 (de) 1993-01-07
CN1068328A (zh) 1993-01-27

Similar Documents

Publication Publication Date Title
NZ243310A (en) Pyrrolo[1,2-a]pyrazine or benzo[g]pyrazino[1,2-a]indole derivatives, pharmaceutical compositions thereof and intermediates therefor
EP1192165B1 (en) Substituted heterocycle fused gamma-carbolines
JP3417566B2 (ja) Ｃｂ２受容体作用化合物
USRE39679E1 (en) Substituted heterocycle fused gamma-carbolines
US5646173A (en) Tricyclic pyrrole derivatives useful as 5-HT selective agents
US5639778A (en) Indoletetralins having dopaminergic activity
US6166040A (en) Indole compounds
AU774337B2 (en) Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
JPH07149723A (ja) １−アミノエチルインドール誘導体
CZ293628B6 (cs) Benzyl(iden)laktamové deriváty a jejich použití a farmaceutické kompozice na jejich bázi
HUP0002843A2 (hu) Új béta-karbolin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
EP1147110A1 (en) Pyrazino(aza)indole derivatives
CA1182823A (en) 1'-substituted-spiro ¬pyrrolidine-3,3'-indoline| -2,2',5-triones
US4041169A (en) Pharmaceutical method for using pyrano-and thiopyranoindole derivatives
EP0220051A1 (en) Isothiazolone derivatives
US5153211A (en) Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4273773A (en) Antihypertensive tricyclic isoindole derivatives
US4003913A (en) Pyrano- and thiopyranoindole derivatives, compositions and methods of use
US3503990A (en) 6-aryl-4,5,6,7-tetrahydro-4-oxoindole derivatives
CZ202292A3 (cs) Způsob zpracování slupek plodu ostropestřce mariánského
US4245095A (en) Indolo isoquinoline compounds
US4307235A (en) Spiro[indoline-3,4'-piperidine]s
US4345081A (en) Spiro[indoline-3,4'-piperidine]s
US3595874A (en) 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
EP0220873B1 (en) Fused bicyclic imides with psychotropic activity